Anacor Pharmaceuticals, Inc. (ANAC)

[surf1944]

8:32AM Anacor Pharma reports successful completion of Pre-NDA communications With the FDA for Tavaborole (ANAC) 6.00 : Co announces that it has successfully completed its pre-NDA communications with the FDA related to tavaborole, its drug candidate for the topical treatment of onychomycosis. In its pre-NDA communications, co achieved concurrence from the FDA on the content and format of the proposed NDA for tavaborole including required data related to safety, efficacy, manufacturing and packaging. Anacor remains on schedule to file the NDA in mid-2013.